Lupovis
PrivateLast Round
Grant
Dec 6, 2021
Total Funding Raised
$916,300
Company Overview
Lupovis is a cybersecurity company that provides a Deception as a Service platform using artificial intelligence to deploy decoys and lure attackers away from valuable assets.
Sector
Cybersecurity
Verticals
Threat Intelligence, Network Security, Incident Response
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lupovis Comparables
Compare Lupovis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CyberTrap Software | 87% | |
| Labyrinth Security Solutions | 85% | |
| Treacle Technologies | 83% | |
Lupovis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 6, 2021 | ||||
| Pre Seed | Oct 28, 2021 |
Lupovis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nauta Capital | Pre Seed |
| Scottish EDGE | Grant |
| University of Strathclyde | Pre Seed |
| Techstart Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 28, 2021
$850K round led by Nauta Capital and Techstart Ventures
Lupovis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lupovis's valuation, stock price, and market status.